In Brief: OTC labels and pharmacists
This article was originally published in The Tan Sheet
Executive Summary
OTC labels and pharmacists: House Resolution introduced May 15 by Reps. Michael Crapo (R-Idaho), Marion Berry (D-Ark.) and Wes Watkins (R-Okla.) states FDA should take appropriate action to "encourage consumers to consult with their pharmacists in connection with the purchase and use of over-the-counter drug products." Intent of the resolution is to encourage FDA to require addition of the phrase "or pharmacist" to the "ask your doctor" directions on OTC labeling. The Joint Commission of Pharmacy Practitioners (formerly NARD), which supports the resolution, urges FDA in a May 15 letter to specify inclusion of "or pharmacists" in its OTC labeling policy. The agency requested comment on the reference to pharmacists in its Feb. 27 proposed rule on OTC label reform ("The Tan Sheet" March 3, p. 5)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning